Current assets cover short-term debt more than twice. Quick ratio 2.47×. 2024 was 6.52×.
Opening company
COMPANY OVERVIEW
Opening company
Org. no. 950 177 365·Aksjeselskap
Grossistvirksomhet og salg av legemidler.
Register details are shown now. Website, social and contact listings fill in as they are found.
administrasjon@octapharma.noBrønnøysundregistrene email
Checking public listings
Company contact from public listings — not a verified direct line to an executive.
Loading annual accounts
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.
Current assets cover short-term debt more than twice. Quick ratio 2.47×. 2024 was 6.52×.
Equity is a large share of total assets. 2024 was 85%.
The operating margin is modest.
Calculated from the annual accounts filed with Brønnøysundregistrene. These bands describe the filed figures. They are not a credit rating. Changes are against the 2024 filing.
Org. no. 950 177 365·Aksjeselskap
Grossistvirksomhet og salg av legemidler.
Company-supplied registry link. Official ownership and availability have not been independently verified.
administrasjon@octapharma.noBrønnøysundregistrene email
Company contact from public listings — not a verified direct line to an executive.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.